Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1503 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Polyplus-transfection S.A.. (5/11/11). "Press Release: Polyplus-transfection and ExcellGene Enter into a Supply Agreement for PEI-based Transfection Reagents". Strasbourg. 2011-05-11
Santhera Pharmaceuticals. (5/9/11). "Press Release: Santhera Presents Data from 2-year Open-label Intervention Study with Catena in Duchenne Muscular Dystrophy at the Myology 2011 Conference". Liestal. 2011-05-09
Aureus Sciences S.A.. (5/9/11). "Press Release: Aureus Pharma Changes Name to Aureus Sciences and Launches a New Life Science Applications Portal". 2011-05-09
Sanofi S.A.. (5/6/11). "Press Release: Combined General Shareholder Meeting of May 6, 2011. »Sanofi-Aventis« Becomes »Sanofi«". Paris. 2011-05-06
bioMérieux S.A.. (5/5/11). "Press Release: bioMérieux and Labor Berlin (Charité Vivantes GmbH) to Establish Center of Excellence in Laboratory Diagnostics". Berlin & Marcy l’Etoile. 2011-05-05
Ipsogen S.A.. (5/2/11). "Press Release: Ipsogen to Present a Study on Genomic Grade in Lobular Carcinoma at the 3rd IMPAKT Breast Conference in Brussels, Belgium". Marseille. 2011-05-02
Transgene S.A.. (4/18/11). "Press Release: Transgene, ChronTech Pharma and Inovio Pharmaceuticals to Collaborate on Heterologous Prime-boost Therapeutic Vaccination against Hepatitis C. Phase I Study to Access Safety and Immunogenicity". Illkirch. 2011-04-18
Ipsen S.A.. (4/18/11). "Press Release: Active Biotech and Ipsen Enter into a Broad Partnership for the Co-development and Commercialization of TASQ in Uro-oncology". Lund & Paris. 2011-04-18
bioMérieux S.A.. (4/12/11). "Press Release: bioMérieux Achieves 100th PREVI Isola Milestone, Installing Its Automated Plate Streaker at Grady Health System". Marcy l’Étoile. 2011-04-12
Ipsogen S.A.. (4/4/11). "Press Release: Ipsogen and Sysmex Establish a Distribution Agreement for the Japanese Market". Marseille. 2011-04-04
Transgene S.A.. (3/31/11). "Press Release: Transgene Announces Completion of Enrolment in HCVac (Phase II Trial) of TG4040 for the Treatment of Chronic Hepatitis C". Illkirch. 2011-03-31
PathoQuest S.A.S.. (3/29/11). "Press Release: French Pathogens Discovery Biotechnology Start-up, PathoQuest SAS, Raises 2m€ with Kurma BioFund in Its First Round of Financing". Paris. 2011-03-29
Ipsogen S.A.. (3/21/11). "Press Release: 2010 Annual Results. Continuing Growth in Sales over the Year (+24%) and Significant Acceleration during the Second Half of 2010 – Greater Control of Operating Expenses". Marseille. 2011-03-21
Transgene S.A.. (3/16/11). "Press Release: Transgene Reports Full Year 2010 Results". Illkirch. 2011-03-16
bioMérieux S.A.. (3/8/11). "Press Release: bioMérieux – 2010 Financial Results". Marcy l’Étoile. 2011-03-08
Cellectis S.A.. (2/28/11). "Press Release: Cellectis Bioresearch Makes Genome Engineering Affordable for All Users". Paris. 2011-02-28
Ipsogen S.A.. (2/16/11). "Press Release: Revenue for the Year 2010 – 8.37M€ (+24%), Acceleration of Sales During the Second Half of 2010 and a Steady Growth in Consolidated Revenue Over the Year". Marseille. 2011-02-16
Ipsogen S.A.. (2/1/11). "Press Release: Ipsogen and Bio-Reference Laboratories Settle Lawsuit". Marseille. 2011-02-01
Cellectis S.A.. (1/20/11). "Press Release: Cellectis Acquires Exclusive License to TAL Effector Patents from University of Minnesota". Paris. 2011-01-20
bioMérieux S.A.. (1/19/11). "Press Release: bioMérieux – 2010 Business Review". Marcy l’Étoile. 2011-01-19
Cerep S.A.. (1/18/11). "Press Release: Cerep to Reorganize Its Operations in France". Paris. 2011-01-18
Ipsogen S.A.. (1/17/11). "Press Release: Ipsogen Acquires a License from Stanford University of LNK Mutations". Marseille. 2011-01-17
Domain Therapeutics S.A.. (1/17/11). "Press Release: Domain Therapeutics and Merck Serono Announce an Agreement to Develop Drugs for Parkinson’s Disease. Merck Serono to Develop Domain Therapeutics’ mGluR4 Allosteric Modulators". Strasbourg. 2011-01-17
Medigene AG. (1/13/11). "Press Release: MediGene Concludes an Agreement with Laboratoires Expanscience for the Commercialization of Veregen in France". Martinsried. 2011-01-13
Polyplus-transfection S.A.. (1/10/11). "Press Release: Polyplus-transfection Raises EUR 2.5 Million in Latest Funding Round". Strasbourg. 2011-01-10
bioMérieux S.A.. (1/4/11). "Press Release: bioMérieux Expands Customer Services Offer, Appointing James P. Whelan as Executive Vice President, Commercial Services". Marcy l’Étoile. 2011-01-04
Ipsogen S.A.. (12/13/10). "Press Release: Ipsogen Calibrates Its BCR-ABL Assays to the International Scale, a New Progress in Chronic Myeloid Leukemia Management". Marseille. 2010-12-13
Ipsogen S.A.. (12/7/10). "Press Release: Three New Studies on Genomic Grade at 33rd Annual San Antonio Breast Cancer Symposium". Marseille. 2010-12-07
Kurma Partners. (12/6/10). "Press Release: Meiogenix SAS, a French Genomic Start-up Company, Raises 1.2m€ from Investors". 2010-12-06
Bruker Corporation. (12/2/10). "Press Release: Public Hospital Network of Paris (Assistance Publique Hôpitaux de Paris) Has Selected Bruker’s IVD MALDI Biotyper for MALDI-TOF-based Microbial Identification". Paris. 2010-12-02
bioMérieux S.A.. (12/1/10). "Press Release: bioMérieux Restructures Its Clinical Culture Media Business in North America and Announces the Closing of Its Portland, OR Plant". Marcy l’Étoile. 2010-12-01
CIT. (11/25/10). "Press Release: AFSSAPS and GIPC Renew GLP Certification fo CIT. The Company Has Introduced Quality Programs Associated with the New Equipment and Technologies Made Available to Its Clients". Evreux. 2010-11-25
Novalix S.A.S.. (11/16/10). "Press Release: Novalix Acquires a Majority Interest in Graffinity. Graffinity’s Proprietary Fragment-based SPR Drug Discovery Technology Will Be Added to Novalix’s Integrated Chemistry and Biophysical Capabilities". Strasbour 2010-11-16
Wyatt Technology Corporation. (11/16/10). "Press Release: Wyatt Technology Instrumentation Used against Bacteriophage Infections in Dairy Production". Santa Barbara, CA. 2010-11-16
SGS S.A.. (11/15/10). "Press Release: SGS’s Life Sciences Services Plans Expansion of Its Biopharmaceutical and Bioanalytical Testing Services Business in Its Poitiers, France Facility". 2010-11-15
bioMérieux, Inc.. (11/4/10). "Press Release: bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics". Marcy l’Étoile & Lausanne. 2010-11-04
bioMérieux, Inc.. (11/4/10). "Press Release: Presentation. bioMérieux and Biocartis – a Strategic Partnership in Molecular Diagnostics". 2010-11-04
bioMérieux S.A.. (10/26/10). "Press Release: Alain Mérieux Organizes His Succession at the Head of bioMérieux, Entrusting Jean-Luc Bélingard with the Role of Président Directeur Général". Marcy l’Étoile. 2010-10-26
bioMérieux, Inc.. (10/22/10). "Press Release: Business Review for the Nine Months Ended September 30, 2010". Marcy l’Étoile. 2010-10-22
Bruker Corporation. (10/21/10). "Press Release: Bruker Announces Successful Installation of Record-setting Ultra-high Field 17 Tesla Preclinical MRI System at NeuroSpin Research Center in France". Paris. 2010-10-21
Cerenis Therapeutics S.A.. (10/21/10). "Press Release: Cerenis Therapeutics Raises Additional €10 Million to Close €50 Million Series C Financing". 2010-10-21
Ipsogen S.A.. (10/11/10). "Press Release: Results for the First Half of 2010". Marseille. 2010-10-11
Ipsen S.A.. (10/11/10). "Press Release: Ipsen’s Board of Directors Announces Jean-Luc Bélingard’s Departure and the Appointment of Marc de Garidel as New Chairman and CEO". Paris. 2010-10-11
bioMérieux S.A.. (9/20/10). "Press Release: bioMérieux Awarded NHSBT Contract". Marcy-l’Étoile. 2010-09-20
bioMérieux S.A.. (9/13/10). "Press Release: Leicester Upgrades to bioMérieux’s OBSERVA® Data Management Software". 2010-09-13
bioMérieux S.A.. (9/6/10). "Press Release: First-half 2010 Results". Marcy-l’Étoile. 2010-09-06
Ipsogen S.A.. (9/6/10). "Press Release: First-Half 2010 Revenue. A Steady Growth in Consolidated Revenue – +17%". Marseille. 2010-09-06
Agilent Technologies Inc.. (9/1/10). "Press Release: Maquet SA Adopts Agilent Electronic Lab Notebook Paired with Surety Intellectual Property Integrity Protection". Santa Clara, CA & Reston, VA. 2010-09-01
Ipsogen S.A.. (8/30/10). "Press Release: Ipsogen Strengthens Its Patent Position with U.S. Allowance of Additional JAK2 V617F Claims". Marseille. 2010-08-30
Corning Inc.. (8/13/10). "Press Release: Corning to Acquire Plaslab S.A.S. Acquisition to Add Sampling, Testing, and Analysis Consumables to Its Life Sciences Product Portfolio". Corning, NY. 2010-08-13
Cerenis Therapeutics S.A.. (7/26/10). "Press Release: Cerenis Therapeutics Raises EUR 40 Million in Series C Financing. Jean-Pierre Garnier Appointed as Non-executive Director to the Board". Toulouse & Ann Arbor, MI. 2010-07-26
bioMérieux S.A.. (7/22/10). "Press Release: First-half 2010 Business Review". Marcy-l’Étoile. 2010-07-22
Poxel S.A.. (7/8/10). "Press Release: Poxel Raises €16 Million in a Series A Financing to Accelerate Pipeline Development". 2010-07-08
Sanofi-Aventis S.A.. (6/30/10). "Press Release: Sanofi-Aventis to Acquire TargeGen Inc., a US Biopharmaceutical Company. Development of Oral Potent Oncology Medicines for the Treatment of Hematological Malignancies". Paris. 2010-06-30
Protea Biosciences, Inc.. (6/22/10). "Press Release: Protea Biosciences and Mayoly-Spindler Announce Human Clinical Trial for New Biopharmaceutical". Morgantown, WV. 2010-06-22
Chiral Technologies, Inc.. (6/18/10). "Press Release: Chiral Technologies Europe Signs Distribution Agreement with Hichrom". 2010-06-18
Ipsogen S.A.. (6/17/10). "Press Release: Ipsogen Announces the Success of a € 1.9 Million Reserved Capital Increase". Marseille. 2010-06-17
Sanofi-Aventis S.A.. (6/17/10). "Press Release: Jevtana (cabazitaxel) Injection Approved by U.S. FDA After Priority Review. First and Only Therapy to Provide Significant Survival Benefit in Second-line Metastatic Hormone-refractory Prostate Cancer". Pari 2010-06-17
Sartorius Stedim Biotech GmbH. (6/15/10). "Press Release: ATMI and Sartorius Stedim Biotech Extend Global Supply and Marketing Alliance. SSB and ATMI LifeSciences Agree to Add ATMI’s Magnetic Mixer for Single-Use [...]". Danbury, CT & Aubagne. 2010-06-15
Genfit. (5/31/10). "Press Release: Two Major Pre-diabetes Clinical Trials within the IT-Diab Program". Lille & Cambridge, MA. 2010-05-31
bioMérieux S.A.. (5/25/10). "Press Release: bioMérieux Showcases Myla at ASM 2010. New Informatics Solution to Transform the Microbiology Laboratory". Marcy l’Étoile. 2010-05-25
General Electric Company. (5/18/10). "Press Release: GE Healthcare Completes Acquisition of Sanesco, a Leading Healthcare Advisory Services Company in France". Paris. 2010-05-18
Polyplus-transfection S.A.. (4/30/10). "Press Release: Polyplus-transfection SA Appoints Mark Bloomfield as CEO". Strasbourg. 2010-04-30
Exonhit Therapeutics S.A.. (4/26/10). "Press Release: ExonHit to Acquire RedPath Integrated Pathology, Inc. and Accelerate Growth in Molecular Diagnostics". Paris. 2010-04-26
bioMérieux S.A.. (4/21/10). "Press Release: bioMérieux and Knome Sign Startegic Partnership". Marcy l’Étoile & Cambridge, MA. 2010-04-21
bioMérieux S.A.. (4/21/10). "Press Release: bioMérieux – First Quarter 2010 Business Review. Sales Up 6.4% at Constant Exchange Rates and Scope of Consolidation". Marcy l’Étoile. 2010-04-21
Neovacs S.A.. (4/15/10). "Press Release: Neovacs Raises €10 Million in Its Initial Public Offering on Alternext by NYSE Euronext Paris [Not for direct or indirect distribution in the United States, Canada, Australia or Japan]". Paris. 2010-04-15
bioMérieux S.A.. (4/12/10). "Press Release: bioMérieux Acquires from AnagnosTec Database and Expertise for Rapid Microbial Identification Using Mass Spectrometry". Marcy l’Étoile. 2010-04-12
bioMérieux S.A.. (4/12/10). "Press Release: bioMérieux Introduces Myla at ECCMID. New Informatics Solution to Transform the Microbiology Laboratory". Marcy l’Étoile. 2010-04-12
Neovacs S.A.. (4/9/10). "Press Release: Neovacs’ IPO on the Alternext Exchange of NYSE Euronext in Paris – Revised Terms and Conditions [Not for direct or indirect distribution in the United States, Canada, Australia or Japan]". Paris. 2010-04-09
bioMérieux S.A.. (4/8/10). "Press Release: bioMérieux’s PREVI Isola Wins the 2010 – Medical Design Excellence Award. The Award Highlights the Automated Media Streaker's Breakthrough Technology". Marcy l’Étoile. 2010-04-08
Neovacs S.A.. (3/19/10). "Press Release: Neovacs Announces It Plans an Initial Public Offering on the Alternext Exchange of NYSE Euronext in Paris [Not for direct or indirect distribution in the United States, Canada, Australia or Japan]". Paris. 2010-03-19
Oxford Gene Technology Ltd.. (3/18/10). "Press Release: OGT Signs Kreatech as Exclusive Distributor for CytoSure in France. Deal Provides OGT with an Expanded Customer Base for Its Market-leading aCGH Arrays". Oxford. 2010-03-18
Ipsogen S.A.. (3/15/10). "Press Release: 2009 Annual Results. Revenue Growth of 63% Associated with a Substantial Development of Sales of the JAK2 Test, Notably in the United States". Marseille. 2010-03-15
bioMérieux S.A.. (3/8/10). "Press Release: bioMérieux – 2009 Financial Results. Strong Growth in Sales – Up 10.4% at Constant Exchange Rates". Marcy l’Étoile. 2010-03-08
bioMérieux S.A.. (3/8/10). "Press Release: bioMérieux 2015. A Powerful Strategic Vision for 2010–2015, Driven by Innovation and International Development". Marcy l’Étoile. 2010-03-08
Ipsogen S.A.. (3/4/10). "Press Release: Ipsogen Appoints Corinne Danan as Vice President Commercial Operations". Marseille. 2010-03-04
Ipsogen S.A.. (2/17/10). "Press Release: 2009 Annual Revenue – €6.7m. Further Buoyant Growth – +63%". Marseille. 2010-02-17
Fluidigm Corporation. (1/25/10). "Press Release: Fluidigm and IntegraGen Join Forces to Create a Genetic Analysis Service and European Demonstration Lab". South San Francisco, CA & Evry. 2010-01-25
Ipsogen S.A.. (1/25/10). "Press Release: Ipsogen Obtains Option to Acquire License on TET2 Abnormalities to Improve the Diagnosis of Blood-based Disorders". Marseille. 2010-01-25
bioMérieux S.A.. (1/22/10). "Press Release: bioMérieux – 2009 Business Review". Marcy l’Étoile. 2010-01-22
bioMérieux S.A.. (1/14/10). "Press Release: bioMérieux Acquires Chinese Rapid Test Manufacturer Meikang Biotech". Marcy l’Étoile. 2010-01-14
Ipsogen S.A.. (1/11/10). "Press Release: The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer". Paris & Marseille. 2010-01-11
Vivalis S.A.. (1/11/10). "Press Release: Vivalis Announces the Strategic Acquisition of Humalys and the Addition of a New Platform for Generating Human Monoclonal Antibodies". Nantes. 2010-01-11
Adocia S.A.S.. (1/5/10). "Press Release: Adocia Announces Today the Closing of Its Second Financing Round of 14 M€". Lyon. 2010-01-05
AstraZeneca plc. (12/23/09). "Press Release: AstraZeneca to Acquire Infection Research Company Novexel and Expand Collaboration with Forest Laboratories". 2009-12-23
Exonhit Therapeutics S.A.. (12/16/09). "Press Release: ExonHit Announces the Success of Its Capital Increase. Gross Proceeds €15.6 Million". Paris. 2009-12-16
bioMérieux S.A.. (12/3/09). "Press Release: Long-term Strategic Partnership between bioMérieux and the CEA to Develop Innovative Diagnostic Technologies for Infectious Disease Management". Marcy l’Étoile. 2009-12-03
Bruker Corporation. (12/2/09). "Press Release: World’s First 1000 MHz NMR Spectrometer Now Offers Research Capabilities to European Scientists, Following Its Successful Installation at CRMN in Lyon, France". Lyon. 2009-12-02
Exonhit Therapeutics S.A.. (11/5/09). "Press Release: ExonHit Therapeutics Announces the Appointment of Its New Chief Financial Officer". Paris. 2009-11-05
Domain Therapeutics S.A.. (11/4/09). "Press Release: Domain Therapeutics Announces Successful Completion of the First Milestone in Its Research Agreement with Takeda Pharmaceutical". Strasbourg. 2009-11-04
bioMérieux S.A.. (11/3/09). "Press Release: Alain Pluquet’s Appointment". Marcy l’Étoile. 2009-11-03
Micromet, Inc.. (10/29/09). "Press Release: Micromet and Sanofi-Aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody". Bethesda, MD. 2009-10-29
Sanofi-Aventis S.A.. (10/1/09). "Press Release: Sanofi-Aventis to Acquire Fovea, a French Biopharmaceutical Opthalmology Company". Paris. 2009-10-01
sanofi-aventis S.A.. (9/16/09). "Press Release: Sanofi-aventis Receives Complete Response Letter from the FDA for Eplivanserin (Ciltyri®) Submission". Paris. 2009-09-16
Sanofi-Aventis S.A.. (9/11/09). "Press Release: Encouraging Phase II Results with Teriflunomide in Patients with Relapsing Multiple Sclerosis. Safety and Efficacy Data Presented at the 2009 ECTRIMS". Paris. 2009-09-11
Sanofi-Aventis S.A.. (9/11/09). "Press Release: Phase 3 Trial of Aflibercept in Metastatci Pancreatic Cancer Discontinued. Phase 3 Studies in Colorectal Cancer, Non-small Cell Lung Cancer, and Prostate Cancer Continue with over 70 Percent Enrollment Comp 2009-09-11
Alizé Pharma. (9/1/09). "Press Release: Alizé Pharma Closes EUR 3 Million (USD 4.2M) Financing Round". Lyon. 2009-09-01
Exonhit Therapeutics S.A.. (6/26/09). "Press Release: ExonHit Announces the Departure of Its Chief Financial Officer". Paris. 2009-06-26
Cerep S.A.. (6/17/09). "Press Release: Cerep and Servier Establish a New Collaboration Agreement for Drug Drug Discovery and Lead Optimization". Paris. 2009-06-17
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top